Compare ALV & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALV | BLCO |
|---|---|---|
| Founded | 1953 | 1853 |
| Country | Sweden | Canada |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 7.1B |
| IPO Year | 1997 | 2022 |
| Metric | ALV | BLCO |
|---|---|---|
| Price | $118.17 | $20.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 15 |
| Target Price | ★ $131.25 | $21.93 |
| AVG Volume (30 Days) | 855.8K | ★ 977.3K |
| Earning Date | 10-23-2026 | 10-28-2026 |
| Dividend Yield | ★ 3.41% | N/A |
| EPS Growth | ★ 18.78 | N/A |
| EPS | ★ 5.36 | N/A |
| Revenue | ★ $10,815,000,000.00 | $5,101,000,000.00 |
| Revenue This Year | $2.43 | $7.83 |
| Revenue Next Year | $2.15 | $5.90 |
| P/E Ratio | $21.90 | ★ N/A |
| Revenue Growth | 4.09 | ★ 6.47 |
| 52 Week Low | $99.16 | $14.44 |
| 52 Week High | $132.17 | $21.40 |
| Indicator | ALV | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 48.71 | 67.50 |
| Support Level | $113.85 | $15.30 |
| Resistance Level | $119.30 | $21.38 |
| Average True Range (ATR) | 3.02 | 0.62 |
| MACD | -0.42 | 0.03 |
| Stochastic Oscillator | 23.12 | 71.81 |
Autoliv Inc is a developer, manufacturer, and supplier of passive safety systems to the automotive industry with a broad range of product offerings. Its product portfolio includes passive safety systems for commercial vehicles, battery cut-off switches, safety solutions for riders of motorcycles and bikes, airbags (including steering wheels and inflators), seatbelts, etc. Geographically, the group operates in the Americas, Europe, China, and Asia, excluding China, of which the maximum revenue is generated from its business in the Americas.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes brands like Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, and surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xiidra and Miebo that treat various eye complications.